The lung mucosa: a critical environmental battleground.

Am J Med

Pulmonary Disease Division, State University of New York, Stony Brook 11794.

Published: October 1991

The entirety of the lung mucous membrane and epithelial surface are exposed to the environment; react to noxious environmental gases, vapors, and particles; and are under physiologic and humoral mediator control. In recent years much information has been gained regarding the mucous membrane of the tracheobronchial tree, its physiology, and its reaction to environmental hazards. The pharmacologic control of secretion, ciliary beat rate, and net mucus flow governs both the clearance of mucus and the clearance of particles. The physiologic factors that govern this clearance mechanism can be influenced by pharmacologic agents in patients with lung disease and presumably also in patients with purely environmental injury. The effects of ozone on lung function, lung compliance, and airway resistance have been well documented in adults and children. Environmental ozone also alters mucous membrane function, increasing mucociliary secretion rate and peripheral lung clearance. The speed-up in clearance implies an increase in mucous gland secretion, which may act unfavorably when ciliary beat is damaged, glandular hypertrophy is present, or flow-limiting segments exist, as is usually the case in bronchial asthma and chronic obstructive pulmonary disease. Thus, whereas the consequences of ozone may be modest for a normal, healthy individual, they presumably increase hazards for the individual with lung disease or damage. For this reason, efforts should be made to control or limit damage by ozone or other environmental inhalants in such individuals. This goal may be facilitated by a wider knowledge of the pharmacologic control of the mucous membrane.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0002-9343(91)90254-uDOI Listing

Publication Analysis

Top Keywords

mucous membrane
16
particles physiologic
8
pharmacologic control
8
ciliary beat
8
lung disease
8
lung
7
environmental
6
mucous
5
clearance
5
lung mucosa
4

Similar Publications

Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood.

View Article and Find Full Text PDF

Guided bone regeneration therapy based on plaque control of peri-implantitis with follow-up at 7 years.

Hua Xi Kou Qiang Yi Xue Za Zhi

February 2025

Dept. of Periodontics, Nanjing Stomatological Hospital, Affiliated Hosptital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing 210008, China.

Peri-implantitis is a pathologic condition associated with dental plaque that occurs in the implant tissue and is characterized by inflammation of the mucous membrane surrounding the implant, followed by the progressive loss of supporting bone. In this study, a case of guided bone regeneration therapy based on plaque control of peri-implant inflammation was reported. Four years after surgery for the left second premolar implant, the patient presented with "left lower posterior tooth swelling and discomfort for more than 2 years".

View Article and Find Full Text PDF

[Mucosal disorders of the tongue].

Ned Tijdschr Geneeskd

January 2025

Radboudumc, afd. Mond-Kaak-Aangezichtschirurgie, Nijmegen.

Mucosal diseases of the tongue, such as lingua geographica and lingua villosa, are relatively common and are usually harmless, such as lingua geographica and lingua villosa, but can also be more serious, such as oral cavity carcinoma of the tongue. In this article we discuss the diagnosis and treatment of the most common mucosal diseases of the tongue. The influence of underlying systemic conditions, certain medications and preventive advice are also discussed.

View Article and Find Full Text PDF

PANoptosis in intestinal epithelium: its significance in inflammatory bowel disease and a potential novel therapeutic target for natural products.

Front Immunol

January 2025

Institute of Medical Genetics and Reproductive Immunity, School of Medical Science and Laboratory Medicine, Jiangsu College of Nursing, Huai'an, China.

The intestinal epithelium, beyond its role in absorption and digestion, serves as a critical protective mechanical barrier that delineates the luminal contents and the gut microbiota from the lamina propria within resident mucosal immune cells to maintain intestinal homeostasis. The barrier is manifested as a contiguous monolayer of specialized intestinal epithelial cells (IEC), interconnected through tight junctions (TJs). The integrity of this epithelial barrier is of paramount.

View Article and Find Full Text PDF

Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease.

World J Gastroenterol

January 2025

Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung 404328, Taiwan.

This article discusses the recent study written by Koizumi . Alcohol-associated liver disease (ALD) is a major cause of liver-related morbidity and mortality, which is driven by complex mechanisms, including lipid accumulation, apoptosis, and inflammatory responses exacerbated by gut barrier dysfunction. The study explored the therapeutic potential of elafibranor, a dual peroxisome proliferator-activated receptor alpha/delta agonist.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!